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Twomanuscripts published recently in Cell Stem Cell (Lluis et al., 2008 [this issue]; Marson et al., 2008) show
thatWnt-b-catenin signaling stimulates nuclear reprogramming. These twostudies, usingdistinct reprogram-
ming methods, offer insights into the mechanisms underlying acquisition and maintenance of pluripotency.
With the demonstration of induced plurip-
otent stem cell (iPSC) techniques (Taka-
hashi and Yamanaka, 2006), Yamanaka
and colleagues started a race to generate
pluripotent cells that could be used
to develop new cell-based therapies
for human disease. The use of onco-
genes and DNA-integrating viruses
to generate iPSCs offer obvious
hurdles because they introduce
a proven risk of oncogenic transfor-
mation of differentiated cells derived
from iPSCs. The race has pro-
gressed primarily along two related
tracks; first, by elucidating the mo-
lecular events important for reprog-
ramming, and second, by applying
new techniques and knowledge to
prevent oncogenic events. Despite
breathtaking progress in just two
years, we still know relatively little
about the underlying mechanisms
by which somatic cell nuclei are re-
programmed to pluripotency. The
combined findings reported by the
Cosma (Lluis et al., 2008 [this issue
of Cell Stem Cell]) and Jaenisch
(Marson et al., 2008) groups consti-
tute progress along both tracks of
inquiry by identifying molecular
components of Wnt signaling that
stimulate nuclear reprogramming.
The canonical Wnt signaling path-
way centers on the stability of b-cat-
enin (Figure 1A). In the absence of
a Wnt signal, the GSK-3b kinase
phosphorylates b-catenin and
targets it for ubiquitin-mediated
destruction. Activation of the path-
way by a Wnt ligand inhibits GSK-
3b activity and results in the
accumulation of b-catenin. Stable
b-catenin can interact with DNA-
binding Tcf factors in the nucleus,
where the complex activates tran-
scription of target genes. Treating
ES cells with Wnt or inhibiting GSK-3
activity can stimulate ESC self-renewal
and support pluripotency (Sato et al.,
2004).
In this issue, the Cosma group tested
whether Wnt signaling could also stimu-
late nuclear reprogramming (Lluis et al.,
2008). Instead of taking the popular
iPSC approach, they induced cell
fusion between ESCs and other
nonpluripotent cell types (neural
stem cells [NSCs]), thymocytes, or
fibroblasts). Treating cells with
Wnt3a or an inhibitor of GSK-3
activity elevated reprogramming fre-
quencies up to 80-fold relative to
nontreated controls (Figure 1B). In-
creased reprogramming occurred
either when the ESCs were treated
prior to fusion, or when the fused
cultures were treated soon after
fusion. In contrast, treating the dif-
ferentiated cells with Wnt prior to fu-
sion failed to improve the efficiency
of reprogramming. The authors con-
cluded that Wnt signaling turned on
a ‘‘reprogrammer’’ factor from plu-
ripotent nuclei that allowed more ef-
fective conversion of differentiated
cell nuclei to a pluripotent program.
A similar effect of Wnt signals was
reported by the Jaenisch group
using the iPSC method of nuclear
reprogramming (Marson et al.,
2008). Without drug selection, the
iPSC induction process (using
Oct4, Sox2, Klf4, and c-myc viruses;
OSKC) generates heterogeneous
colony types; some are ESC-like,
and others continue to proliferate,
but are neither pluripotent nor re-
semble ESCs. Reprogramming
without c-myc virus (OSK) increases
the percentage of ESC-like clones
within the total number of colonies;
however, a large decrease in total
colony number effectively reduces
the rate of pluripotent clones relative
to combined OSKC virus treatment
(Nakagawa et al., 2008). Adding
Figure 1. Wnt Signaling Stimulation of
Reprogramming
(A) Diagram depicting the relationship between some
members of the Wnt-b-catenin signaling pathway.
(B) A reprogrammer activity (R) found in ESC (green with blue
nucleus) converts the nucleus of the differentiated cell (red
with yellow nucleus) to a pluripotent state after cell fusion.
Wnt3a, inhibition of GSK-3, or b-catenin expression in ESC
or fused cells stimulated reprogrammer activity (thick arrows).
(C) Differentiated cells can be reprogrammed to ESC-like state
by viral transduction of Oct4, Sox2, Klf4, and c-myc. Some
cells (light blue with orange nucleus) continue to proliferate
after viral transduction but fail to become ESC-like. Addition
of Wnt3a media allowed more efficient reprogramming in the
absence of c-myc-expressing virus.
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hanced reprogramming efficiency about
20-fold while maintaining a high specific-
ity for ESC-like colonies (Figure 1C;
Marson et al., 2008). The gains were
abolished by adding an inhibitor (ICG-
001) that targets b-catenin-CBP complex
transcriptional activity, suggesting that
target genes of b-catenin-dependent
transcription provide a ‘‘reprogrammer’’
function.
While the identity of the ‘‘reprogram-
mer’’ downstream of b-catenin activity
remains unknown, the most likely candi-
dates have already been examined. Since
c-myc is a Tcf-b-catenin target gene in
cancer cells, and Wnt3a effectively re-
placed c-myc-expressing viruses in iPSC
experiments, it might have been that the
observed Wnt-b-catenin effects were
due to an elevation of c-myc expression
in treated cells. However, there was no
detectable increase in c-myc expression
in either iPSC or fusion experiments (Lluis
et al., 2008; Marson et al., 2008). Nanog
was another good candidate for the
‘‘reprogrammer’’ because it can elevate
fusion-mediated reprogramming (Silva
et al., 2006) and is also a downstream
target of Tcf3-mediated repression
(Pereira et al., 2006). And yet, Nanog
expression was also not altered in re-
sponse to the levels of Wnt-b-catenin
that improved reprogramming during cell
fusion. Thus, while we do not yet under-
stand the molecular consequences of
b-catenin-mediated reprogrammer activ-
ity, fusion experiments tell us that b-cate-
nin cannot act alone, as it requires some
other factor(s) present in ESCs, but
absent from NSC, thymocytes, or fibro-
blasts.466 Cell Stem Cell 3, November 6, 2008 ª20One important clue that may help eluci-
date how b-catenin stimulates reprog-
ramming comes from the analysis of
different levels of Wnt-b-catenin activity
present during fusion experiments. Re-
programming failed when fusion was
performed with ESCs harboring complete
genetic knockout of GSK-3 activity, or
with ESCs that expressed high levels of
b-catenin. Treatments that caused rela-
tively modest increases in b-catenin
levels and reporter gene activity provided
the greatest benefit for reprogramming ef-
ficiency. These results were consistent
with reports that very high levels of Wnt
activity found in GSK-3 double-knockout
cells coincided with differentiation of
ESCs (Ying et al., 2008). In addition, the
requirement for a specific range of b-cat-
enin activity could provide an explanation
for why b-catenin’s effect was not discov-
ered in the original Yamanaka screen (Ta-
kahashi and Yamanaka, 2006), and why
inhibiting GSK-3 activity failed to stimu-
late iPSC reprogramming (Marson et al.,
2008). Perhaps, in the case of b-catenin
signals, it is possible to have too much
of a good thing?
Collectively, these findings leave us
with the interesting question of what b-
catenin does differently when present at
high levels versus low levels. The answer
to this question could apply to other, non-
pluripotent stem cells, as nuanced
responses to varying Wnt-b-catenin
levels have been described in physiologi-
cally relevant contexts with hair follicle
stem cells and hematopoietic stem cells
(Lowry et al., 2005; Fleming et al., 2008).
I believe it is safe to say that the common
depictions of Wnt signaling in models (i.e.,
Figure 1) are guilty of simplifying the ef-08 Elsevier Inc.fects of b-catenin to a singular effect on
Tcf proteins. To accommodate the dose-
dependent effects of b-catenin, the field
must consider that different concentra-
tions of activated b-catenin either could
mediate distinct Tcf protein effects, or
even impact non-Tcf partners. Improved
understanding of the specific molecular
consequences of varying levels of b-cate-
nin activity in stem cells will require direct
investigation and may clarify the range of
cellular responses that are observed in
each case.
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